Biomedical Engineering Reference
In-Depth Information
[94] allen TM, Cullis pr. liposomal drug delivery systems: from concept to clinical
applications. adv Drug Deliv rev 2013;
65
:36-48.
[95] Urbinati g, Marsaud v, renoir JM. anticancer drugs in liposomal nanodevices: a target
delivery for a targeted therapy. Curr Top Med Chem 2012;
12
:1693-1712.
[96] Kumar p, gulbake a, Jain sK. liposomes a vesicular nanocarrier: potential advance-
ments in cancer chemotherapy. Crit rev Ther Drug Carrier syst 2012;
29
:355-419.
[97] Fanciullino r, Ciccolini J. liposome-encapsulated anticancer drugs: still waiting for
the magic bullet? Curr Med Chem 2009;
16
:4361-4371.
[98] szoka F Jr, papahadjopoulos D. Comparative properties and methods of preparation of
lipid vesicles (liposomes). annu rev Biophys Bioeng 1980;
9
:467-508.
[99] szoka F Jr, papahadjopoulos D. procedure for preparation of liposomes with large
internal aqueous space and high capture by reverse-phase evaporation. proc natl acad
sci U s a 1978;
75
:4194-4198.
[100] Maherani B, arab-tehrany e, Kheirolomoom a, reshetov v, stebe MJ, linder M.
optimization and characterization of liposome formulation by mixture design. analyst
2012;
137
:773-786.
[101] Mozafari Mr. liposomes: an overview of manufacturing techniques. Cell Mol Biol
lett 2005;
10
:711-719.
[102] Muthu Ms, Kulkarni sa, Xiong J, Feng ss. vitamin e Tpgs coated liposomes
enhanced cellular uptake and cytotoxicity of docetaxel in brain cancer cells. int J pharm
2011;
421
:332-340.
[103] sailor MJ, park Jh. hybrid nanoparticles for detection and treatment of cancer. adv
Mater 2012;
24
:3779-3802.
[104] Yoshida M, Watanabe Y, sato M, Maehara T, aono h, naohara T, hirazawa h,
horiuchi a, Yukumi s, sato K, nakagawa h, Yamamoto Y, sugishita h, Kawachi K.
Feasibility of chemohyperthermia with docetaxel-embedded magnetoliposomes as
minimally invasive local treatment for cancer. int J Cancer 2010;
126
:1955-1965.
[105] Cittadino e, Ferraretto M, Torres e, Maiocchi a, Crielaard BJ, lammers T, storm g,
aime s, Terreno e. Mri evaluation of the antitumor activity of paramagnetic liposomes
loaded with prednisolone phosphate. eur J pharm sci 2012;
45
:436-441.
[106] McClements DJ. nanoemulsions versus microemulsions: terminology, differences, and
similarities. soft Matter 2012;
8
:1719-1729.
[107] shakeel F, shafiq s, haq n, alanazi FK, alsarra ia. nanoemulsions as potential
vehicles for transdermal and dermal delivery of hydrophobic compounds: an over-
view. expert opin Drug Deliv 2012;
9
:953-974.
[108] Kotta s, Khan aW, pramod K, ansari sh, sharma rK, ali J. exploring oral nanoemul-
sions for bioavailability enhancement of poorly water-soluble drugs. expert opin Drug
Deliv 2012;
9
:585-598.
[109] McClements DJ, rao J. Food-grade nanoemulsions: formulation, fabrication, prop-
erties, performance, biological fate, and potential toxicity. Crit rev Food sci nutr
2011;
51
:285-330.
[110] rajpoot p, pathak K, Bali v. Therapeutic applications of nanoemulsion based drug
delivery systems: a review of patents in last two decades. recent pat Drug Deliv Formul
2011;
5
:163-172.
[111] sarker DK. engineering of nanoemulsions for drug delivery. Curr Drug Deliv
2005;
2
:297-310.
Search WWH ::
Custom Search